1725 related articles for article (PubMed ID: 19440019)
1. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
Cho KS; Seo JW; Park SJ; Lee YH; Choi YD; Cho NH; Yang SC; Hong SJ
Urol Int; 2009; 82(3):306-11. PubMed ID: 19440019
[TBL] [Abstract][Full Text] [Related]
2. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
Stein JP; Clark P; Miranda G; Cai J; Groshen S; Skinner DG
J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
[TBL] [Abstract][Full Text] [Related]
3. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
Stein JP; Penson DF; Lee C; Cai J; Miranda G; Skinner DG
J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213
[TBL] [Abstract][Full Text] [Related]
4. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
[TBL] [Abstract][Full Text] [Related]
5. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
[TBL] [Abstract][Full Text] [Related]
6. Urethral recurrence after cystoprostatectomy: implications for urinary diversion and monitoring.
Nieder AM; Sved PD; Gomez P; Kim SS; Manoharan M; Soloway MS
Urology; 2004 Nov; 64(5):950-4. PubMed ID: 15533484
[TBL] [Abstract][Full Text] [Related]
7. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
8. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
[TBL] [Abstract][Full Text] [Related]
9. Contemporary management of the urethra in patients after radical cystectomy for bladder cancer.
Clark PE; Hall MC
Urol Clin North Am; 2005 May; 32(2):199-206. PubMed ID: 15862617
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and outcomes of urethral recurrence following radical cystectomy.
Boorjian SA; Kim SP; Weight CJ; Cheville JC; Thapa P; Frank I
Eur Urol; 2011 Dec; 60(6):1266-72. PubMed ID: 21871713
[TBL] [Abstract][Full Text] [Related]
11. Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature.
Stein JP; Penson DF; Wu SD; Skinner DG
J Urol; 2007 Sep; 178(3 Pt 1):756-60. PubMed ID: 17631333
[TBL] [Abstract][Full Text] [Related]
12. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
Liedberg F; Chebil G; Månsson W
Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
[TBL] [Abstract][Full Text] [Related]
13. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
[TBL] [Abstract][Full Text] [Related]
14. Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy.
Hassan JM; Cookson MS; Smith JA; Johnson DL; Chang SS
J Urol; 2004 Sep; 172(3):882-4. PubMed ID: 15310989
[TBL] [Abstract][Full Text] [Related]
15. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
[TBL] [Abstract][Full Text] [Related]
16. Urethral recurrence in patients with orthotopic ileal neobladders.
Freeman JA; Tarter TA; Esrig D; Stein JP; Elmajian DA; Chen SC; Groshen S; Lieskovsky G; Skinner DG
J Urol; 1996 Nov; 156(5):1615-9. PubMed ID: 8863551
[TBL] [Abstract][Full Text] [Related]
17. Multifactorial, site-specific recurrence model after radical cystectomy for urothelial carcinoma.
Umbreit EC; Crispen PL; Shimko MS; Farmer SA; Blute ML; Frank I
Cancer; 2010 Jul; 116(14):3399-407. PubMed ID: 20564121
[TBL] [Abstract][Full Text] [Related]
18. Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy.
Lin DW; Herr HW; Dalbagni G
J Urol; 2003 Mar; 169(3):961-3. PubMed ID: 12576822
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis, risk factors, and outcome of urethral recurrences following radical cystectomy for bladder cancer in 729 male patients.
Huguet J; Monllau V; Sabaté S; Rodriguez-Faba O; Algaba F; Palou J; Villavicencio H
Eur Urol; 2008 Apr; 53(4):785-92 discussion 792-3. PubMed ID: 17629611
[TBL] [Abstract][Full Text] [Related]
20. Indications for lower urinary tract reconstruction in women after cystectomy for bladder cancer: a pathological review of female cystectomy specimens.
Stein JP; Cote RJ; Freeman JA; Esrig D; Elmajian DA; Groshen S; Skinner EC; Boyd SD; Lieskovsky G; Skinner DG
J Urol; 1995 Oct; 154(4):1329-33. PubMed ID: 7658531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
